Loading company…
Nano Cures develops nanotechnology-based drug delivery systems.
Founded in 2014 and based in Austin, US, Nano Cures develops targeted drug delivery systems using nanoparticles. Its research focuses on delivering therapeutic agents to affected areas for conditions including cancer and autoimmune diseases. In March 2021, it raised USD 90 mn in Pre-IPO funding from Opulence Capital Management to scale its Cures Platform for Covid-19 variants.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in